Framework Contract for Procurement of Drugs and Medicines FY 2026-27

The Center for Disease Control, Punjab, under the Health & Population Department of the Government of Punjab, is inviting sealed bids for a framework contract for the procurement of drugs and medicines during the financial year 2026-27. This is a comprehensive procurement exercise for essential pharmaceutical supplies to support health service delivery across Punjab province. The tender reference is PC-03/Drugs/Medicines/P-III/26-27, and the bidding process follows standardized government procurement procedures as outlined in the bidding document.

Eligible bidders must be registered pharmacies, pharmaceutical manufacturers, or authorized wholesale distributors holding valid drug licenses under the applicable national or provincial drug regulations. Bidders are required to submit documentation demonstrating their eligibility, including business registration, tax records, and proof of manufacturing or distribution authorization. A bid security deposit is required from all participating bidders to ensure seriousness and compliance with bid terms. All bidders must comply with Drug Act and DRAP Act requirements, and documentation of such compliance is mandatory.

Bidders should obtain complete bidding documents directly from the Center for Disease Control, Punjab office. Sealed bids must be submitted by the deadline specified in the tender data sheet, clearly marked with the bid reference number. Bid opening will be conducted by the Procuring Agency on the date announced, and evaluation will follow standardized criteria outlined in Section IV of the bidding document. Prospective bidders are encouraged to seek clarifications on bidding documents well in advance of the submission deadline. Contact the Center for Disease Control, Punjab for detailed information regarding submission procedures, bid specifications, and technical requirements for medicines and pharmaceuticals.

This is a framework contract for pharmaceutical supplies to support health services across Punjab for FY 2026-27. The scope encompasses multiple drug categories requiring DRAP compliance and valid distribution licenses. The structure suggests significant ongoing procurement volume across health facilities in the province. Bidders must maintain quality assurance and cold-chain capabilities where required. This is a recurring annual contract opportunity, though the notice does not specify individual line-item quantities or estimated value.

Who can bid: Eligible bidders must hold valid drug manufacturing or wholesale distribution licenses issued under Pakistan's Drug Act and DRAP regulations. Registration with relevant tax authorities (NTN) and business registration are typically required. Only firms authorized to distribute or manufacture pharmaceutical products in Pakistan may bid. Bidders must demonstrate compliance with all applicable drug quality and safety standards.